What have we learned from a decade of patient involvement in OMERACT and its effect on trial outcome assessments?

Similar Items

• Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study
  od: de Wit, Maarten, i dr.
  Izdano: (2013)
• Two decades with omalizumab: what we still have to learn
  od: Incorvaia, Cristoforo, i dr.
  Izdano: (2018)
• What have we learned in interventional pulmonology in the past decade?
  od: ÖZGÜL, Mehmet Akif, i dr.
  Izdano: (2019)
• 30 years of HIV: what have we learned?
  od: Gazzard, Brian
  Izdano: (2014)
• The first decade of microbial genomics: what have we learned and where are we going next?
  od: Rasko, David A, i dr.
  Izdano: (2005)